Liver Biomarkers in Anorexia Nervosa
Recruiting
- Conditions
- Anorexia Nervosa
- Interventions
- Diagnostic Test: Fibroscan
- Registration Number
- NCT05861375
- Lead Sponsor
- Nantes University Hospital
- Brief Summary
The main goal of the Liver Biomarkers in Anorexia Nervosa (LIBAN) study is to determine the prevalence of liver fibrosis in patient with Anorexia Nervosa.
- Detailed Description
Prevalence of hepatic fibrosis will be non-invasively investigated, in the Anorexia Nervosa inpatient population, using the Fibroscan ®. Furthermore, liver blood markers will be assessed.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Non applicable (NA) Fibroscan Patients with Anorexia Nervosa hospitalized for malnutrition
- Primary Outcome Measures
Name Time Method Liver fibrosis prevalence in patients with Anorexia nervosa Day one Liver stiffness will be assessed using Fibroscan (kPA) within the 24 hours following admission to the endocrinology, diabetology and nutrition department.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Nantes University Hospital
🇫🇷Nantes, Loire-Atlantique, France